Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma

More documents

Recommendations

Info

Robinson JM, Cook JL, Purdam C, Visentini PJ, Ross J, et al. 2001. The VISA-A questionnaire: a valid and reliable index of the clinical severity of Achilles tendinopathy. Br J Sports Med 35:335-41 Rolke R, Baron R, Maier C, Tolle TR, Treede RD, et al. 2006a. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123:231-43 Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, et al. 2006b. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain 10:77-88 Rommel O, Malin JP, Zenz M, Janig W. 2001. Quantitative sensory testing, neurophysiological and psychological examination in patients with complex regional pain syndrome and hemisensory deficits. Pain 93:279-93 Rompe JD, Furia J, Maffulli N. 2009. Eccentric loading versus eccentric loading plus shock-wave treatment for midportion achilles tendinopathy: a randomized controlled trial. Am J Sports Med 37:463-70 Sandkuhler J. 2009. Models and mechanisms of hyperalgesia and allodynia. Physiol Rev 89:707-58 Sarlani E, Greenspan JD. 2003. Evidence for generalized hyperalgesia in temporomandibular disorders patients. Pain 102:221-6 Schaible HG. 2007. Peripheral and central mechanisms of pain generation. Handb Exp Pharmacol:3-28 Scholz J, Mannion RJ, Hord DE, Griffin RS, Rawal B, et al. 2009. A novel tool for the assessment of pain: validation in low back pain. PLoS Med 6:e1000047 Scholz J, Woolf CJ. 2002. Can we conquer pain? Nat Neurosci 5 Suppl:1062-7 Schweinhardt P, Bushnell MC. 2010. Pain imaging in health and disease--how far have we come? J Clin Invest 120:3788-97 Scott AC, McConnell S, Laird B, Colvin L, Fallon M. 2011. Quantitative Sensory Testing to assess the sensory characteristics of cancer-induced bone pain after radiotherapy and potential clinical biomarkers of response. Eur J Pain Segerdahl M. 2006. Multiple dose gabapentin attenuates cutaneous pain and central sensitisation but not muscle pain in healthy volunteers. Pain 125:158-64 Sein ML, Walton J, Linklater J, Appleyard R, Kirkbride B, et al. 2010. Shoulder pain in elite swimmers: primarily due to swim-volume-induced supraspinatus tendinopathy. Br J Sports Med 44:105-13 Serra J, Sola R, Quiles C, Casanova-Molla J, Pascual V, et al. 2009. C-nociceptors sensitized to cold in a patient with small-fiber neuropathy and cold allodynia. Pain 147:46-53 Shenker NG, Haigh RC, Mapp PI, Harris N, Blake DR. 2008. Contralateral hyperalgesia and allodynia following intradermal capsaicin injection in man. Rheumatology (Oxford) 47:1417-21 Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, et al. 2003. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 60:898-904
Silbernagel KG, Brorsson A, Lundberg M. 2011. The majority of patients with Achilles tendinopathy recover fully when treated with exercise alone: a 5-year follow-up. Am J Sports Med 39:607-13 Sindrup SH, Jensen TS. 1999. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83:389-400 Staud R, Vierck CJ, Robinson ME, Price DD. 2004. Spatial summation of heat pain within and across dermatomes in fibromyalgia patients and pain-free subjects. Pain 111:342-50 Stiasny-Kolster K, Magerl W, Oertel WH, Moller JC, Treede RD. 2004. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain 127:773-82 Svensson P, Wang K, Arendt-Nielsen L, Cairns BE. 2008. Effects of NGF-induced muscle sensitization on proprioception and nociception. Exp Brain Res 189:1-10 Tan SC, Chan O. 2008. Achilles and patellar tendinopathy: current understanding of pathophysiology and management. Disabil Rehabil 30:1608-15 Torrance N, Smith BH, Bennett MI, Lee AJ. 2006. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 7:281-9 Tracey I. 2007. Neuroimaging of pain mechanisms. Curr Opin Support Palliat Care 1:109-16 Tracey I. 2008. Imaging pain. Br J Anaesth 101:32-9 Tracey I, Bushnell MC. 2009. How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J Pain 10:1113-20 Tracey I, Ploghaus A, Gati JS, Clare S, Smith S, et al. 2002. Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci 22:2748-52 Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, et al. 2008. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70:1630-5 Treede RD, Meyer RA, Raja SN, Campbell JN. 1992. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 38:397-421 van Wilgen CP, Kaptein AA, Brink MS. 2010. Illness perceptions and mood states are associated with injury-related outcomes in athletes. Disabil Rehabil 32:1576-85 van Wilgen CP, Keizer D. 2011. Neuropathic pain mechanisms in patients with chronic sports injuries: a diagnostic model useful in sports medicine? Pain Med 12:110-7 van Wilgen CP, Konopka KH, Keizer D, Zwerver J, Dekker R. Do patienst with chronic patellar tendinopathy have an altered somatosensory profile? - A Quantitative Sensory Testing (QST) study. Scand J Med Sci Sports. 2011 Sep 13 Veldman PH, Goris RJ. 1996. Multiple reflex sympathetic dystrophy. Which patients are at risk for developing a recurrence of reflex sympathetic dystrophy in the same or another limb. Pain 64:463-6
Page 2:
Quantitative Sensory Testing (QST)
Page 5 and 6:
Promotores: Prof. dr. M.M.R.F. Stru
Page 7 and 8:
Paranimfen Marten Harbers Aribert B
Page 9 and 10:
Contents 3.3.4. Sensory changes at
Page 11:
0 Contents Chapter 5 Do patients wi
Page 14:
Chapter 1 General introduction
Page 17 and 18:
1. General introduction stimuli. C-
Page 19 and 20:
1. General introduction Patients re
Page 21 and 22:
1. General introduction 0 drugs (NS
Page 23 and 24:
1. General introduction Table 1-2:
Page 26 and 27:
Chapter 2 Bilateral sensory abnorma
Page 28 and 29:
2. Bilateral abnormalities in neuro
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46:
Page 49 and 50:
3. Somatosensory function and neuro
Page 51 and 52:
0 3. Somatosensory function and neu
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62: 3. Somatosensory function and neuro
Page 67 and 68: 4. QST and neuropathic pain mechani
Page 81 and 82: 5. QST in patients with tendinopath
Page 94 and 95: Chapter 6 General discussion and Su
Page 96 and 97: 6. General discussion and Summary s
Page 98 and 99: 6. General discussion and Summary s
Page 100 and 101: 6. General discussion and Summary T
Page 102 and 103: 6. General discussion and Summary Q
Page 104 and 105: 6. General discussion and Summary S
Page 106 and 107: References Abate M, Silbernagel KG,
Page 108 and 109: de la Llave-Rincon AI, Fernandez-de
Page 110 and 111: Kehlet H, Jensen TS, Woolf CJ. 2006
Page 114 and 115: Visentini PJ, Khan KM, Cook JL, Kis
Page 116 and 117: Nederlandse samenvatting Met de ont
Page 118 and 119: Acknowledgement To produce a work s
show all

Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?